Management of Major Bleeding Events in Patients Treated With Rivaroxaban Versus Warfarin: Results From the ROCKET AF Trial

被引：0

作者：

Piccini, Jonathan P. ^{[1
]}

Garg, Jyotsna ^{[2
]}

Patel, Manesh R. ^{[1
]}

Lokhnygina, Yuliya ^{[3
]}

Goodman, Shaun G. ^{[4
,5
]}

Becker, Richard C. ^{[1
]}

Berkowitz, Scott D. ^{[6
]}

Breithardt, Gunter ^{[7
]}

Hacke, Werner ^{[8
]}

Halperin, Jonathan L. ^{[9
]}

Hankey, Graeme I. ^{[10
,11
]}

Nessel, Christopher C. ^{[12
]}

Mahaffey, Kenneth W. ^{[1
]}

Singer, Daniel E. ^{[13
,14
]}

Califf, Robert M. ^{[15
]}

Fox, Keith A. ^{[16
,17
]}

机构：

[1] Duke Clin Rsch Inst, Dept Med, Div Cardiol, Durham, NC USA

[2] Duke Clin Rsch Inst, Stat Grp, Durham, NC USA

[3] Duke Clin Rsch Inst, Dept Biostat & Bioinformat, Durham, NC USA

[4] Univ Toronto, St Michaels Hosp, Canadian Heart Rsch Cntr, Toronto, ON, Canada

[5] Terrence Donnelly Heart Cntr, Toronto, ON, Canada

[6] Bayer HealthCare Pharmaceut, Global Therapeut Rsch, Cardiovasc Pharmacol, Montville, NJ USA

[7] Hosp Univ Munster, Dept Cardiol & Angiol, Munster, Germany

[8] Heidelberg Univ, Dept Neurol, Heidelberg, Germany

[9] Mt Sinai, Icahn Sch Med, Mt Sinai Med Cntr, Cardiovasc Inst, New York, NY USA

[10] Univ Western Australia, Sch Med & Pharmacol, Dept Neurol, Perth, WA 6009, Australia

[11] Royal Perth Hosp, Stroke Unit, Perth, WA 6001, Australia

[12] Janssen Rsch & Dev, Clin Rsch, Raritan, NJ USA

[13] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[14] Harvard Univ, Sch Med, Boston, MA USA

[15] Duke Translat Med Inst, Dept Med, Div Cardiol, Durham, NC USA

[16] Univ Edinburgh, Cntr Cardiovasc Sci, Edinburgh, Midlothian, Scotland

[17] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland

来源：

CIRCULATION | 2013年 / 128卷 / 22期

关键词：

Atrial fibrillation; Stroke; Risk factors;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

15879

引用

页数：2

共 50 条

[21] Thromboembolic and Major Bleeding Events With Rivaroxaban Versus Warfarin Use in a Real-World Setting
Russo-Alvarez, Giavanna
Martinez, Kathryn A.
Valente, Megan
Bena, James
Hu, Bo
Luxenburg, Jennifer
Chaitoff, Alexander
Ituarte, Catherine
Brateanu, Andrei
Rothberg, Michael B.
ANNALS OF PHARMACOTHERAPY, 2018, 52 (01) : 19 - 25
[22] THROMBOLYTIC THERAPY IN ANTICOAGULATED PATIENTS: CASE SERIES FROM RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION (ROCKET AF)
Chen, Sean
Hellkamp, Anne
Becker, Richard
Berkowitz, Scott
Breithardt, Guenter
Fox, Keith
Hacke, Werner
Halperin, Jonathan
Hankey, Graeme
Mahaffey, Kenneth
Nessel, Christopher
Piccini, Jonathan
Singer, Daniel
Patel, Manesh
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 446 - 446
[23] Rivaroxaban vs. warfarin with concomitant aspirin use in patients with atrial fibrillation: findings from the ROCKET AF trial
Shah, R.
Hellkamp, A. S.
Berkowitz, S. D.
Breithardt, G.
Fox, K. A. A.
Mahaffey, K. W.
Nessel, C. C.
Piccini, J. P.
Singer, D. E.
Patel, M. R.
EUROPEAN HEART JOURNAL, 2015, 36 : 345 - 345
[24] Relationship between center time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial
Piccini, J. P.
Harrell, F.
Lokhnygina, Y.
Wang, J.
Oppenheimer, L.
Patel, M. R.
Singer, D. E.
Mahaffey, K. W.
Fox, K. A. A.
Califf, R. M.
EUROPEAN HEART JOURNAL, 2012, 33 : 968 - 969
[25] Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial
Wong, Ka Sing Lawrence
Hu, Dai Yi
Oomman, Abraham
Tan, Ru-San
Patel, Manesh R.
Singer, Daniel E.
Breithardt, Guenter
Mahaffey, Kenneth W.
Becker, Richard C.
Califf, Robert
Fox, Keith A. A.
Berkowitz, Scott D.
Hacke, Werner
Hankey, Graeme J.
STROKE, 2014, 45 (06) : 1739 - 1747
[26] OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL
Breithardt, Guenter
Berkowitz, Scott
Baumgartner, Helmut
Hellkamp, Anne
Piccini, Jonathan
Stevens, Susanna
Lokhnygina, Yuliya
Patel, Manesh
Halperin, Jonathan
Singer, Daniel
Hankey, Graeme
Hacke, Werner
Becker, Richard
Nessel, Christopher
Mahaffey, Kenneth
Califf, Robert
Fox, Keith
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E339 - E339
[27] Individual and Regional Determinants of Time in Therapeutic Range Among Patients Randomized to Warfarin in the ROCKET AF Trial of Rivaroxaban
Singer, Daniel E.
Hellkamp, Anne S.
Halperin, Jonathan L.
Mahaffey, Kenneth W.
Becker, Richard C.
Breithardt, Gunter
Hankey, Graeme J.
Hacke, Werner
Patel, Manesh R.
Califf, Robert M.
Fox, Keith A.
CIRCULATION, 2011, 124 (21)
[28] Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial
Kochar, Ajar
Hellkamp, Anne S.
Lokhnygina, Yuliya
Jones, W. Schuyler
Becker, Richard C.
Berkowitz, Scott D.
Breithardt, Gunter
Fox, Keith A. A.
Halperin, Jonathan L.
Hankey, Graeme J.
Mahaffey, Kenneth W.
Nessel, Christopher C.
Singer, Daniel E.
Piccini, Jonathan P.
Patel, Manesh R.
CLINICAL CARDIOLOGY, 2018, 41 (01) : 39 - 45
[29] EFFICACY AND SAFETY OF RIVAROXABAN COMPARED WITH WARFARIN IN PATIENTS WITH CAROTID ARTERY DISEASE AND NONVALVULAR ATRIAL FIBRILLATION: INSIGHTS FROM THE ROCKET AF TRIAL
Kochar, Ajar
Hellkamp, Anne
Lokhnygina, Yuliya
Jones, William
Becker, Richard
Berkowitz, Scott
Breithardt, Guenter
Fox, Keith
Halperin, Jonathan
Hankey, Graeme
Mahaffey, Kenneth
Nessel, Christopher
Singer, Daniel
Piccini, Jonathan
Patel, Manesh
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 737 - 737
[30] Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial
Masayasu Matsumoto
Masatsugu Hori
Norio Tanahashi
Shin-ichi Momomura
Shinichiro Uchiyama
Shinya Goto
Tohru Izumi
Yukihiro Koretsune
Mariko Kajikawa
Masaharu Kato
Hitoshi Ueda
Kazuma Iekushi
Satoshi Yamanaka
Masahiro Tajiri
Hypertension Research, 2014, 37 : 457 - 462

← 1 2 3 4 5 →